A Look at Teva’s Earnings Estimates ahead of Q2 Results
Teva Pharmaceutical Industries (TEVA) is set to announce its Q2 2018 earnings results on August 2. Teva is expected to perform better amid the company’s restructuring plans, lower-than-expected Copaxone market share, and sales losses due to competition and reducing debt burden.